mortality bond

You’d be forgiven for thinking that the insurance-linked securities market was only about catastrophe risk securitization if you looked at our Deal Directory and in recent months it has been. However, according to panelists at ratings agency Standard & Poor’s recent Insurance 2012 Conference there’s life in life insurance-linked securitization yet, particularly in the securitization […]

Risk Management Solutions (RMS) have issued a press release regarding their involvement in the recently completed Vita Capital IV Ltd. mortality risk catastrophe bond issued on behalf of Swiss Re. It contains a little more detail on the risk modelling tools used to get the transaction to market which we thought would interest our readers. […]

Swiss Re have now published a press release on the completion of their latest catastrophe bond transaction so we felt it worth publishing some of their comments on the transaction. The latest Vital Capital IV Ltd. issuance closed earlier this week, as we wrote here, and secured them $180m of cover for mortality events such […]

Swiss Re have successfully closed the latest in their Vita series of mortality catastrophe bond deals and the two tranches have received their official ratings today. The transaction, which has been issued by their Vita Capital IV Ltd. Cayman Islands domiciled SPV, began marketing in mid-July seeking to secure $100m of cover under the mortality catastrophe […]

The catastrophe bond and insurance-linked security investment community will be delighted that they have some new opportunities to put their funds to work in transactions offering diversification opportunities today. First, Munich Re began marketing their Queen Street III Capital European windstorm catastrophe bond today and now Swiss Re are returning to the market with two […]

Swiss Re’s Vita Capital IV Ltd. mortality risk insurance-linked securities have had their rating downgraded by Standard & Poor’s due to the perceived heightened exposure that tsunami’s present to the transaction. Vita Capital IV Ltd’s Series III is an insurance-linked securitization which is exposed to increases in mortality in the U.S. and Japan over a […]

The Series III notes of Swiss Re’s Vita Capital VI Ltd. mortality insurance-linked security transaction which was issued in October 2010 have been placed on CreditWatch negative by Standard & Poor’s as they have exposure to increased mortality levels in Japan.

Risk Management Solutions (RMS) has provided some details on the risk analysis undertaken for the recent Vita Capital IV Ltd. mortality catastrophe bond issued by Swiss Re. The press release from RMS follows below.

Swiss Re have announced completion of their latest issuance under the Vita Capital mortality catastrophe bond scheme. The latest two series of notes have been issued under Vita Capital IV Ltd. and enables Swiss Re to transfer $175m of extreme mortality risk to the capital markets.

Swiss Re have begun marketing for two new series of mortality catastrophe bond notes to be issued by the Vita Capital IV Ltd. special purpose vehicle which is domiciled in the Cayman Islands. These two series of notes will add to the two series Swiss Re issued through Vita Capital IV in the last twelve […]